Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation.
Shouval R, Waters NR, Gomes ALC, Zuanelli Brambilla C, Fei T, Devlin SM, Nguyen CL, Markey KA, Dai A, Slingerland JB, Clurman AG, Fontana E, Amoretti LA, Wright RJ, Hohl TM, Taur Y, Sung AD, Weber D, Hashimoto D, Teshima T, Chao NJ, Holler E, Scordo M, Giralt SA, Perales MA, Peled JU, van den Brink MRM. Shouval R, et al. Clin Cancer Res. 2023 Jan 4;29(1):165-173. doi: 10.1158/1078-0432.CCR-22-1254. Clin Cancer Res. 2023. PMID: 36322005 Free PMC article.
The combination of cyclosporine and mycophenolate mofetil is less effective than cyclosporine and methotrexate in the prevention of acute graft-versus host disease after stem-cell transplantation from unrelated donors.
Yerushalmi R, Shem-Tov N, Danylesko I, Shouval R, Nagler A, Shimoni A. Yerushalmi R, et al. Among authors: shouval r. Am J Hematol. 2017 Mar;92(3):259-268. doi: 10.1002/ajh.24631. Epub 2017 Feb 1. Am J Hematol. 2017. PMID: 28052467 Free article.
Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma.
Danylesko I, Shouval R, Shem-Tov N, Yerushalmi R, Jacoby E, Besser MJ, Shimoni A, Davidson T, Beider K, Mevorach D, Fried S, Nagler A, Avigdor A. Danylesko I, et al. Among authors: shouval r. Bone Marrow Transplant. 2021 May;56(5):1134-1143. doi: 10.1038/s41409-020-01156-y. Epub 2020 Dec 3. Bone Marrow Transplant. 2021. PMID: 33268830 Free PMC article. Clinical Trial.
Risk stratification using FLT3 and NPM1 in acute myeloid leukemia patients autografted in first complete remission.
Shouval R, Labopin M, Bomze D, Baerlocher GM, Capria S, Blaise D, Hänel M, Forcade E, Huynh A, Saccardi R, Milone G, Zuckerman T, Reményi P, Versluis J, Esteve J, Gorin NC, Mohty M, Nagler A. Shouval R, et al. Bone Marrow Transplant. 2020 Dec;55(12):2244-2253. doi: 10.1038/s41409-020-0936-z. Epub 2020 May 10. Bone Marrow Transplant. 2020. PMID: 32388535
Anti-α4β7 integrin monoclonal antibody (vedolizumab) for the treatment of steroid-resistant severe intestinal acute graft-versus-host disease.
Danylesko I, Bukauskas A, Paulson M, Peceliunas V, Gedde-Dahl D Y T, Shimoni A, Shouval R, Griskevicius L, Floisand Y, Nagler A. Danylesko I, et al. Among authors: shouval r. Bone Marrow Transplant. 2019 Jul;54(7):987-993. doi: 10.1038/s41409-018-0364-5. Epub 2018 Oct 24. Bone Marrow Transplant. 2019. PMID: 30356163 Clinical Trial.
Immunological effects of nilotinib prophylaxis after allogeneic stem cell transplantation in patients with advanced chronic myeloid leukemia or philadelphia chromosome-positive acute lymphoblastic leukemia.
Varda-Bloom N, Danylesko I, Shouval R, Eldror S, Lev A, Davidson J, Rosenthal E, Volchek Y, Shem-Tov N, Yerushalmi R, Shimoni A, Somech R, Nagler A. Varda-Bloom N, et al. Among authors: shouval r. Oncotarget. 2017 Jan 3;8(1):418-429. doi: 10.18632/oncotarget.13439. Oncotarget. 2017. PMID: 27880933 Free PMC article.
97 results